Background: Neurofibromatosis 1 (NF1) is an autosomal dominantly inherited disorder
Introduction
Neurofibromatosis 1 (NF1) is a relatively common (1:3,500 newborns 1 ) autosomal dominantly inherited genetic disorder, caused by a spectrum of mutations affecting the neurofibromatosis 1 (Nf1) gene. The Nf1 gene is located at 17q11.2, spans more than 350
Kbs and comprises 60 exons. To date, more than 200 separate mutations have been identified. 2 About 50% of NF1 cases occur in patients with unaffected parents and are believed to represent spontaneous mutations. (Table 1 ).
In addition to the diagnostic criteria listed in Table 1 , affected patients are prone to developing a number of specific neoplastic and non-neoplastic conditions at an increased frequency. The most commonly encountered tumors in patients with NF1 include neurofibromas and optic gliomas. Malignant peripheral nerve sheath tumors develop from pre-existing plexiform neurofibromas in approximately 2-16% of patients 4 , and are the leading cause of death in NF1 patients. Pheochromocytomas and juvenile chronic myeloid leukemia are also seen with increased frequency. Examples of common non-neoplastic conditions include poorly-characterized high signal intensity lesions on T2-weighted Magnetic
Resonance (MR) images of the brain known as "unidentified bright objects", learning disabilities, seizures, secondary hypertension and macrocephaly. Commonly seen soft tissue lesions in the oral cavity include neurofibromas and enlarged fungiform papillae.
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Skeletal findings include scoliosis-like spinal curvature, short stature, tibial pseudoarthrosis and dysplastic lesions of the skeleton. Certain osseous abnormalities, such as sphenoid dysplasia, are considered a diagnostic feature for NF1 (Table 1) . Although not restricted to NF1, over 50% of patients with an osseous defect of the greater wing of the sphenoid bone have NF1. The nature of these hard tissue lesions is poorly defined, but can involve bones that develop by both intramembranous and endochondral ossification. These lesions are generally assumed to represent abnormal development of mesodermal elements and hence are considered primary osseous dysplasias. In some, but not all cases, an adjacent neurofibroma or other soft tissue lesion that is presumed to directly erode bone is implicated.
Skeletal lesions specific to the jaws include 6 enlarged mandibular foramen and canals, branched mandibular canals, widening of the coronoid notch, deformity of the condylar head, lengthening of the condylar neck, irregularity of the inferior mandibular cortex, intrabony cyst-like lesions and thinning and lateral bowing of the ramus. Also noted on CT analysis is the presence of an increased amount of fat-like soft tissue immediately adjacent to the affected ramus.
We report 2 patients with NF1 who presented with aggressive central giant cell granulomas (CGCGs) of the jaws. In both cases, the clinical course was characterized by significant osseous destruction, poor response to treatment and numerous recurrences.
Case Presentation:
Case 1:
In 1996, a12 year-old boy presented with a large mass of the right palate. Intra-oral examination revealed significant palatal expansion (Figure 1 . At one year follow-up, no evidence of recurrence was noted.
Case 2:
A 34 year old female presented with fullness of her right mandibular symphysis area.
Her past medical history was significant for a CGCG of the anterior mandible that had been resected at10 years of age. Serum parathyroid hormone (PTH) and calcium were within normal limits. At age 20, the patient underwent reconstructive surgery with autologous bone grafting and osseointegrated dental implants. During the procedure, a small osseous defect was noted in the surgical field, which on histological examination proved to be a recurrent Currently there are no reliable criteria for correlating clinical aggressiveness with histological presentation 9 . Recurrences are not uncommon, with an estimated 5 year disease-free success rate of only 75% following conventional surgical therapy. 10 The rate of recurrence is even more prominent among young males.
CGCG most likely represents a non-neoplastic reactive process. 11 Proposed etiologies include intraosseous hemorrhage 12 , trauma 13 , faulty bone development and abnormal repair of bone. Arguing in favor of a reactive process is the occasional association of CGCGs with other pre-existing bone lesions, such as fibrous dysplasia, 14 Pagets disease of bone 15 , central odontogenic fibroma 16, 17 , traumatic bone cyst 18 and ossifying fibroma 19, 20 . However, the possibilities that some subtypes of CGCG of the jaws (e.g. those associated with syndromes) may represent a neoplastic process 21, 22 , akin to the giant cell tumor of bone, 23, 24 or have a systemic component, 25 has not been conclusively ruled out.
In CGCGs, the multinucleated giant cells (MGCs) are often concentrated in areas of hemorrhage, adjacent to blood vessels. Although the MGCs seen in CGCG share some similarities with the osteoclast 26, 27 , there are enough phenotypic differences to suggest that these may not be true osteoclasts 28 . It is generally accepted that these MGCs develop as a result of cell-cell fusion of mononuclear cells 29 . Noonan syndrome, an entity of its own right, is believed to be the result of the independent segregation of a both classical NF1 phenotype and a Noonan syndrome phenotype. 42 The observation that the genes responsible for these 2 conditions are located on separate chromosomes does not rule out the possibility of an as yet undefined interaction between neurofibromin and the Noonan syndrome gene product SHP-2. However, the basis for this apparent association between these 2 conditions and CGCGs of the jaws remains unclear. Alternatively, the association between NF1 and CGCG could represent a true genetic linkage; resulting from defects or deletions of two or more genes that map near each other on the same region of a chromosome. Arguing against a genetic linkage is the lack of direct evidence of a specific genetic basis for CGCG.
We believe that the increased incidence of CGCGs of the jaws in patients with NF1 most likely represents an inherent susceptibility to intraosseous trauma and/or hemorrhage in bone previously altered by an underlying osseous dysplasia. This qualitatively abnormal bone would be more susceptible to developing CGCG-like lesions in response to as of yet unidentified factors such as excessive mechanical stress and/or vascular fragility.
In addition to sphenoid dysplasia, patients with NF1 have an increased incidence of additional skeletal dysplasias including scoliosis, thinning and/or bowing of the weight bearing long bones, pseudoarthrosis, and ill-defined fibrocystic lesions of bone 51 .
Although little is known about the underlying basis for the development of dysplastic bone in NF1 52 , several possible mechanisms have been proposed. These include a direct pressure effect from adjacent excessive soft tissue on developing and/or remodeling bone, altered function of the Nf1 gene product (neurofibromin), or loss of function of other genes coded for either within or contiguous to the deleted portion of the Nf1 gene.
Traditionally, the presence of altered bone in NF1 has been attributed to a direct pressure effect of excessive soft tissue, presumably from an adjacent neurofibroma, on developing and/or remodeling bone. However, this fails to account for the significant number of cases in which adjacent neurofibromas cannot be demonstrated. For example, histological analysis of a large number of biopsies from patients with tibial pseudoarthrosis 53 , which is seen in 1-4% in children with NF1, revealed the presence of neurofibroma-like tissue in only 40% of cases. In 45% of cases, a highly cellular non-specific fibrovascular tissue devoid of neural/Schwannian elements is noted.
The role of the Nf1 gene in skeletal development has not been well characterized, although the demonstration of Nf1 mRNA expression and its protein product, neurofibromin, in both osteoblasts and osteoclasts suggests that it may play a role in both osteogenesis and bone homeostasis 54 . Specifically, the Nf1 gene codes for the neurofibromin protein, a putative tumor suppressor protein with GTPase-activating function that appears to be involved in the down regulation of ras signal transduction 55 . Ras activation plays an important role in cellular proliferation and differentiation. Nf1 mutations would therefore be expected to result in increased ras signal transduction. In support of this, it has been demonstrated 54 that mice embryos heterozygous for Nf1 have higher levels of a number of specific downstream products of ras activation (phosphorylated p42 and p44 MAP kinases).
Yu et al 56 recently demonstrated that Nf1+/-(haploinsufficient) mice had normal bone mass but a tendency to decreased bone homeostasis compared to wild type. Specifically, loss of one Nf1 allele was associated with deregulated Ras signaling in bone marrow osteoprogenitor cells, decreased osteoblastic induction potential and premature apoptosis of osteoblasts. However, Nf1 haploinsuffiency alone was not sufficient to cause bone lesions, The observation that Nf1 haploinsuffiency alone is not sufficient to cause bone lesions 56 implies that other events (e.g. loss of the remaining Nf1 allele, loss of an additional gene or an adverse change in the microenvironment) are required prior to the development of CGCG-like lesions in the bone.
Conclusion
We report 2 patients with NF1 who presented with central giant cell granulomas (CGCGs) of the jaws. In both cases, the clinical course was characterized by significant osseous destruction and recurrence.
While the presence of CGCGs of the jaws in patients with NF1 could represent a coincidental association or a genetic linkage, we propose that this phenomenon is most likely related to NF1-mediated osseous dysplasia. Compared to normal bone, the Nf1-haploinsufficient bone in a patient with neurofibromatosis 1 may be less able to remodel in response to as of yet unidentified stimuli (e.g. excessive mechanical stress and/or vascular fragility), and consequently may be more susceptible to developing CGCG-like lesions.
Alternatively, the CGCG in NF1 patients could represent a true neoplasm, resulting from additional, as of yet unidentified, genetic alterations to Nf1-haploinsufficient bone. The diagnostic criteria for NF-1 are met in an individual if two or more of the following are found:
• Six or more café-au-lait macules over 5 mm in greatest diameter in prepubertal individuals and over 15 mm in greatest diameter in postpubertal individuals.
• Two or more neurofibromas of any type or one plexiform neurofibroma.
• Freckling in the axillary or inguinal region.
• Optic glioma.
• Two or more Lisch nodules (iris hamartomas).
• A distinctive osseous lesion such as sphenoid dysplasia or thinning of long bone cortex with or without pseudarthrosis.
• A first-degree relative (parent, sibling, or offspring) with NF-1 by the above criteria.
Note: Although not part of the NIH Consensus Development Conference recommendations, it has been recommended that infants with multiple café-au-lait macules should be reassessed annually until age 10 years for the development of additional diagnostic criteria 63 .
